JOHN ALLAHHAM: Open Payments
NPI 1538120126 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,265 in 61 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,265
Food & beverage: $1,265
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $259 |
| ABBVIE INC. | 14 | $202 |
| Otsuka America Pharmaceutical, Inc. | 10 | $197 |
| Teva Pharmaceuticals USA, Inc. | 6 | $128 |
| Alkermes, Inc. | 4 | $98 |
| Vanda Pharmaceuticals Inc. | 4 | $93 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $69 |
| Janssen Pharmaceuticals, Inc | 3 | $44 |
| Biogen, Inc. | 2 | $43 |
| HARMONY BIOSCIENCES LLC | 1 | $41 |
Products named: Auvelity, VRAYLAR, REXULTI, LYBALVI, ABILIFY MAINTENA, AUSTEDO XR, FANAPT, CAPLYTA.
Industry payments across TN — which companies pay providers there.
